Belite Bio, Inc
BLTE NASDAQHealthcare ★★★★★Latest Earnings FY2026 Q2
Date
Aug 12, 2026
ET
EPS Est.
-0.73
EPS Actual
-0.70
Revenue Est.
--
Revenue Actual
--
Next Earnings Report
Date
Nov 9, 2026 · Mon
Time
Your time zone matches ET
After-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
-0.80
Revenue Est.
--
Company Overview
Belite Bio, Inc (ticker BLTE) is listed on NASDAQ with a market cap of about $6.46B. Its next earnings report (FY2026 Q3) is expected on Nov 9, 2026 (ET), After-market, with consensus EPS of -0.80. In the last 15 reported quarters, EPS beat consensus estimates 6 times.
Actual EPS TrendRecently15Term · Mar 31, 2023 → FY2026 Q2
Mar 31, 2023Range: -1.04 ~ -0.25FY2026 Q2
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 12, 2026 | FY2026 Q2 | -0.73 | -0.70 | -- | -- |
| May 20, 2026 | -- | -0.60 | Above forecast↑-0.34 | -- | -- |
| Mar 2, 2026 | -- | -0.56 | Above forecast↑-0.38 | $16.7M | -- |
| Nov 10, 2025 | -- | -0.53 | Below forecast↓-0.65 | -- | -- |
| Aug 11, 2025 | -- | -0.47 | -0.50 | -- | -- |
| May 13, 2025 | -- | -0.36 | Below forecast↓-0.45 | -- | -- |
| Mar 17, 2025 | -- | -0.30 | -0.32 | -- | -- |
| Nov 12, 2024 | -- | -0.30 | -0.28 | -- | -- |
| Aug 9, 2024 | -- | -0.28 | -0.31 | -- | -- |
| May 13, 2024 | -- | -0.34 | Above forecast↑-0.27 | -- | -- |
| Mar 11, 2024 | -- | -0.36 | Above forecast↑-0.25 | -- | -- |
| Nov 13, 2023 | -- | -0.31 | Below forecast↓-0.40 | -- | -- |
| Aug 8, 2023 | -- | -0.24 | -0.26 | -- | -- |
| May 10, 2023 | -- | -0.20 | Below forecast↓-0.33 | -- | -- |
| Mar 31, 2023 | -- | -0.22 | Below forecast↓-1.04 | -- | -- |
Original Filings (SEC)
Earnings Release6-K · 2026-08-13 ↗
Earnings Release6-K · 2026-08-11 ↗
Earnings Release6-K · 2026-05-20 ↗
Annual20-F · 2026-03-31 ↗
Earnings Release6-K · 2026-03-02 ↗
Earnings Release6-K · 2025-11-10 ↗
Earnings Release6-K · 2025-08-11 ↗
Earnings Release6-K · 2025-05-14 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
